Document is current
Any future updates will be listed below
-
Authors
Strauss, Gregory P.
Macdonald, Kelsey I.
Ruiz, Ivan
Raugh, Ian M.
Bartolomeo, Lisa A.
James, Sydney H.
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R21-MH122863)
National Institute of Mental Health (R01MH116039)
- License Information
-
More Information
Article History
Received: 21 January 2021
Accepted: 30 March 2021
First Online: 21 April 2021
Declarations
:
: G. P. Strauss is one of the original developers of the Brief Negative Symptom Scale (BNSS) and receives royalties and consultation fees from ProPhase LLC in connection with commercial use of the BNSS and other professional activities; these fees are donated to the Brain and Behavior Research Foundation. Dr. Strauss has received honoraria and travel support from ProPhase LLC for training pharmaceutical company raters on the BNSS. In the past two years, Dr. Strauss has consulted for and/or been on the speaker bureau for Minerva Neurosciences, Acadia, and Lundbeck pharmaceutical companies. All other authors have no conflicts to report.
Free to read: This content has been made available to all.
